scholarly journals Iatrogenic Nocardia otitidiscaviarum after PICC line placement

IDCases ◽  
2020 ◽  
Vol 22 ◽  
pp. e00986
Author(s):  
Steven Douedi ◽  
Mustafa Fadhel ◽  
Swapnil Patel
Keyword(s):  
Line Placement ◽  
Picc Line ◽  
Nocardia Otitidiscaviarum

scholarly journals Persistent Left Superior Vena Cava Identified during Peripherally Inserted Central Catheter Line Placement

2019 ◽  
Vol 5 (02) ◽  
pp. 64-66
Author(s):  
Arvind Borde ◽  
Vivek Ukirde
Keyword(s):  
Superior Vena Cava ◽  
Superior Vena ◽  
Vena Cava ◽  
Peripherally Inserted Central Catheter ◽  
Central Catheter ◽  
Left Superior Vena Cava ◽  
Anatomical Variant ◽  
Persistent Left Superior Vena ◽  
Line Placement ◽  
Picc Line

Abstract Introduction A persistent left superior vena cava (SVC) is found in 0.3 to 0.5% of the general population. It is seen in up to 10% of the patients with a congenital cardiac anomaly, being the most common thoracic venous anomaly, and is usually asymptomatic. Being familiar with such anomaly could help clinicians avoid complications during the placement of central lines, Swan-Ganz catheters, peripherally inserted central catheter (PICC) lines, dialysis catheters, defibrillators, and pacemakers. Case Presentation We describe a case of persistent left SVC which was noted after placement of a PICC line. A 5-year-old male child was hospitalized for evaluation and management of leukemia. He required PICC line placement for chemotherapy. He was noted to have a persistent left SVC during the procedure under fluoroscopic guidance and subsequently correct placement of PICC line in right SVC. Discussion This anatomical variant can pose iatrogenic risks if the clinician does not recognize it. A central catheter that tracks down the left mediastinal border may also be in the descending aorta, internal thoracic vein, superior intercostal vein, pericardiophrenic vein, pleura, pericardium, or mediastinum. Conclusion Our case is significant because the patient was diagnosed with double SVC on table only followed by the placement of PICC line into the right SVC. This case strongly demonstrates the importance of knowing the thoracic venous anomalies.

Verifying PICC Line Placement Using ECG Technology

2015 ◽  
Vol 20 (4) ◽  
pp. 249
Author(s):  
Lucy Van Elzen ◽  
Shanti Lackey ◽  
Amy Vanterpool
Keyword(s):  
Line Placement ◽  
Picc Line

Brachial Arteriovenous Fistula as a Complication of Placement of a Peripherally Inserted Central Venous Catheter: A Case Report and Review of the Literature

2006 ◽  
Vol 72 (9) ◽  
pp. 833-836 ◽  
Author(s):  
Hoang S. Tran ◽  
Brian J. Burrows ◽  
William A. Zang ◽  
David C. Han
Keyword(s):  
Central Venous Catheter ◽  
Arteriovenous Fistula ◽  
Duplex Ultrasound ◽  
Venous Catheter ◽  
Central Venous ◽  
Arterial Tree ◽  
Line Placement ◽  
Term Administration ◽  
History Of ◽  
Picc Line

Peripherally inserted central venous catheter (PICC) lines have become a frequently used method of intravenous access for long-term administration of antibiotics, chemotherapy, and parenteral nutrition. Catheter-related complications involving the arterial tree are rare. We report a case of a 25-year-old woman with a history of difficult PICC line placement that presented with an arteriovenous fistula in the left arm. Duplex ultrasound confirmed the diagnosis of a brachial artery-to-brachial vein arteriovenous fistula (AVF), and the patient underwent surgical repair. To our knowledge, this is the first reported case of an AVF resulting from PICC line placement. Correction of AVF is indicated to alleviate symptoms as well as to prevent future complications.

Abstract TP277: Stroke Related Limb Weakness Confers Thrombotic Complications With PICC Lines

Stroke ◽  
2013 ◽  
Vol 44 (suppl_1) ◽  
Author(s):  
Mohammad Ibrahim ◽  
Ravjot Sodhi ◽  
Aaron Nizam ◽  
Nabiha Khakoo ◽  
Siddhart Mehta ◽  
...  
Keyword(s):  
Predictive Value ◽  
Small Sample Size ◽  
Subsequent Development ◽  
Small Sample ◽  
Stroke Patients ◽  
Dvt Prophylaxis ◽  
Line Placement ◽  
Line Insertion ◽  
Increased Risk ◽  
Picc Line

Introduction: A peripherally inserted central catheter (PICC line) is a form of intravenous access that can be used for a prolonged period, which lowers the rate of infection. Our study aims to prove that PICC line insertion predicts a higher rate of Deep Vein Thrombosis (DVT), especially in those receiving the PICC line in a weaker arm. Methods: We conducted a retrospective analysis of stroke patients admitted to NeuroICU between September 2010 and October 2011 at a community teaching hospital. Patient records were evaluated for PICC line placement, DVT, Pulmonary Embolism (PE) development, and anticoagulant status. Odds ratios were calculated for the development of DVT and PE for PICC patients, as well as the outcomes for PICC line patients based on arm strength as defined with motor strength scale using SPSS software version 20. Results: The study included a total of 307 patients (mean age = 62.5 +/- 17.2, 51% female). Ninety-nine patients had a PICC line inserted, 22 of which developed DVT, including 10 patients who appeared to have PICC Line Related Large Venous Thrombosis. The presence of a PICC line conferred an increased risk (OR= 5.18, 95% CI, 2.40-11.2) for the development of a DVT. Patients who had a PICC line placed in a weaker arm (mean strength = 2.17) were more likely to develop a DVT than patients with a PICC line in a stronger arm (mean strength = 3.07) p<0.05. Patients given DVT prophylaxis were less likely to develop a DVT (OR = 0.32, 95% CI, .004 - .252) p < 0.05. Twenty-one patients had a CT chest angiogram performed, including six patients who had evidence of a PE. Of these six patients, one patient had a PICC line placement with subsequent development of DVT followed by PE. PICC line placement and DVT had no predictive value on the development of PE due to the small sample size. Conclusions: Our data suggests that patients who had a PICC line placed into a weaker strength arm had an increased risk of DVT in the same arm and that DVT prophylaxis significantly decreases this risk. Further studies should evaluate the predictive value of PICC line insertion with the risk of developing PE in stroke patients.

Recurrent deep venous thrombosis complicating PICC line placement in two patients with cystic fibrosis and activated protein C-resistance

1998 ◽  
Vol 28 (7) ◽  
pp. 552-553 ◽  
Author(s):  
Mark J. Hogan ◽  
Brian D. Coley ◽  
William E. Shiels II. ◽  
Elizabeth D. Allen ◽  
Karen S. McCoy
Keyword(s):  
Cystic Fibrosis ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Protein C ◽  
Activated Protein C ◽  
Activated Protein C Resistance ◽  
Line Placement ◽  
Picc Line

scholarly journals PICC line placement in neonates – Importance of lateral view radiograph

2019 ◽  
Vol 6 (2) ◽  
pp. 46
Author(s):  
Vikram Bhaskar ◽  
Krishna Murari ◽  
Harshitha Addagatla ◽  
Mamta Jajoo
Keyword(s):  
Lateral View ◽  
Line Placement ◽  
Picc Line

scholarly journals Deep Vein Thrombosis: The Incidence Post-PICC Line Placement

2017 ◽  
Vol 06 (03) ◽  
Author(s):  
Altawan A ◽  
Golchian D ◽  
Iljas J ◽  
Patel B ◽  
Bazzi M
Keyword(s):  
Deep Vein Thrombosis ◽  
Vein Thrombosis ◽  
Line Placement ◽  
Picc Line ◽  
Deep Vein

scholarly journals 256. PICC Complications Are Common Reasons for ED Visits After PJI

2021 ◽  
Vol 8 (Supplement_1) ◽  
pp. S234-S235
Author(s):  
Lefko T Charalambous ◽  
Billy Kim ◽  
Ayden Case ◽  
Ian Duensing ◽  
Meredith Brown ◽  
...  
Keyword(s):  
Revision Surgery ◽  
Board Member ◽  
Health Board ◽  
Research Support ◽  
Potential Cost ◽  
Educational Support ◽  
Material Support ◽  
Line Placement ◽  
Ed Visits ◽  
Picc Line

Abstract Background Peri-prosthetic joint infection (PJI) is a devastating complication after total joint arthroplasty (TJA) requiring surgical intervention and prolonged parenteral antibiotics. Often plagued by complications, the purpose of this study was to characterize the postoperative PICC (peripherally-inserted central catheter) line related complications and readmissions. Causes for 90-Day ED Visits after Revision Surgery for PJI. The figure quantifies causes for ED visits after PJI revision surgery with subsequent PICC line placement. Readmissions from ED are highlighted in blue. PICC-specific problems at ED visit. The figure quantifies the specific PICC-line problems that brought patients to the ED. Readmissions from ED are highlighted in blue. Methods We retrospectively queried an institutional database for total hip (THA) and total knee (TKA) arthroplasty patients from January 2015 through December 2020 that developed a PJI and required PICC placement. Patient demographics, comorbidities, readmissions, and emergency department (ED) visits were collected. Results 889 patients (48.3% female) with a mean age of 64.6 years (18.7-95.2) underwent 435 THA and 454 TKA that were revised for PJI. The cohort had 275 (30.9%) 90-day ED visits and 284 readmissions (31.9%). Of ED visits, 51 (18.5%) were PICC-related, with only five (9.8%) leading to readmission for a PICC complication. Average time from discharge to PICC ED visit was 26.2 days (0.3-89.4). The most common reasons for 90-day ED visit after revision and PICC line placement were issues related to the joint replacement or wound site (“MSK”, n=116, 42.2%) and PICC complaints (n=51, 18.5%). A multivariable logistic regression demonstrated that non-Caucasian race (OR 2.24, 95% CI 1.24-4.04, p=0.007) and younger age (OR 0.98, 95% CI 0.95-1.00, p=0.035) were associated with PICC-related ED visits. Malpositioning (41.2%) and occlusion (35.3%) were the most common PICC complications leading to ED presentation. Conclusion PICC complications are common after PJI treatment accounting for nearly 20% of 90-day ED visits. Of these, malpositioning and occlusion of the PICC line occupy the vast majority of these complaints. This high level of utilization early in the course of outpatient parenteral antibiotic therapy represents areas of optimization and potential cost containment in the postoperative care of PJI patients. Disclosures William Jiranek, MD, Depuy Synthes (Other Financial or Material Support, Royalty/Licensing) Michael Bolognesi, MD, Heron Therapeutics, Inc. (Consultant)Total Joint Orthopedics, Inc. (Other Financial or Material Support, Royalty/Licensing)Zimmer Biomet Holdings, Inc. (Other Financial or Material Support, Royalty/Licensing) Thorsten Seyler, MD/PhD, Depuy Synthes (Other Financial or Material Support, Resident Educational Support)Extrel Therapeutics (Board Member, Shareholder)Heraeus Medical (Consultant)MiCare Path (Board Member, Shareholder)OREF (Grant/Research Support)Pattern health (Board Member)Restor3D (Other Financial or Material Support, Royalties)Smith+Nephew, Inc. (Grant/Research Support, Speaker’s Bureau)Stryker (Other Financial or Material Support, Resident Educational Support)Total Joint Orthopedics, Inc. (Consultant)Wolters Kluwer Health (Other Financial or Material Support, Royalties)Zimmer Biomet (Grant/Research Support)

Sign in / Sign up

Export Citation Format

Share Document